Join
Live feed
·
INSIDERFilingvia Quantisnow
Vertex Pharmaceuticals Incorporated logo

EVP, Chief Technical Ops. Off. Atkinson Edward Morrow Iii was granted 4,962 shares, covered exercise/tax liability with 1,530 shares and sold $1,381,090 worth of shares (2,848 units at $484.93), increasing direct ownership by 3% to 20,727 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VRTX· Vertex Pharmaceuticals Incorporated
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VRTX (Vertex Pharmaceuticals Incorporated) and more on Quantisnow.